Billionaire Profile

Global Rank

#1719

Image: Public domain | via Wikimedia Commons

Alexey Repik

CEO, R-Pharm

Real-Time Net Worth

$2.3B

As of December 2025

Age

Source

Pharmaceuticals

Industry

healthcare

Citizenship

Biography

Alexey Repik, a prominent figure in Russian business and public life, is the founder of R-Pharm, a leading pharmaceutical company. With an estimated net worth of $2.3 billion, Repik's wealth stems from his ventures in the healthcare sector. His career began in the healthcare industry in 1995. Repik has also been actively involved in public service, serving as the Chairman of Delovaya Rossiya (Business Russia), an organization that represents private, non-resource-based companies. His achievements include building a global pharmaceutical enterprise and contributing to the development of the Russian pharmaceutical industry. He has been recognized for his contributions with several awards, including the Medal of the Order "For Merit to the Fatherland".

Wealth Over Time

In-Depth Profile

Early Life

Alexey Evgenievich Repik was born on August 27, 1979, in Moscow, Russia. His father is a physicist and his mother is a technical scientist. He graduated from the Higher School of Economics in 2003 with a degree in economics and enterprise management.

Rise to Success

Repik started his career in the healthcare sector in 1995. In 2001, he founded R-Pharm. Initially, the company focused on the distribution of rare medicines. R-Pharm expanded, establishing branches in several countries including the US, Japan, and Turkey. By 2017, the Japanese corporation Mitsui & Co. acquired a 10% share in R-Pharm for $200 million. Repik's success led him to be ranked on the Forbes list of richest people in Russia.

Key Business Strategies

R-Pharm's business strategy included securing government contracts and expanding internationally. The company participated in government programs to provide medicines to the population, which increased sales. R-Pharm established manufacturing sites and research centers in various countries to enhance its global footprint.

Philanthropy

Repik has been involved in social activities and philanthropy. He founded the Youth Entrepreneurial Initiative Foundation and, together with the Russian Orthodox Church, the “Quench My Griefs” Charitable Foundation. He has also been donating to the construction of a large shelter for dogs in Yaroslavl.

Career Milestones

1995

First job

Began working in healthcare and pharmaceuticals.

2001

Founded R-Pharm

Established R-Pharm, a pharmaceutical company.

2014

President of Delovaya Rossiya

Elected president of Delovaya Rossiya.

2017

Mitsui Investment

Mitsui & Co. acquired 10% shares of R-Pharm.

2019

Chairman of Delovaya Rossiya

Became chairman of Delovaya Rossiya.

2021

Investment in eApteka

R-Pharm, with Sberbank, invested in eApteka.

2025

Acquired Eapteka

Acquired the pharmacy service 'Eapteka' from Sberbank.

Philanthropy & Social Impact

Education

Youth Entrepreneurial Initiative Foundation

$XB

Founded venture fund to support young entrepreneurs

Animal Welfare

Dog Shelter Construction

$XB

Donating for construction of a large shelter for dogs in Yaroslavl

Business Philosophy & Leadership

Notable Quotes

""I have no plane; I have no yacht; not even an island, that's what is the most pity.""

Controversies & Challenges

2023

UK Sanctions

Listed in the UK Sanctions List due to his position as Chairman of R-Pharm, which receives financing from the Russian Direct Investment Fund.

2023

Involvement in Mariupol

Accused of profiting from government contracts in the Russian-occupied city of Mariupol.